The prognosis depends on stage on histology of the cell type.

- Stage 1 has a 90% 5-year survival rate.

- Stage 2 has a 50% 5-year survival rate.

- Stage 3 gas a 30 % 5-year survival rate.

- Sagte 4 has a 5% 5-year survival rate.

Papillary RCC has the best 5-year survival rate, 90%. Clear cell cancer subtype has second-best 5-year survival, 70%.